Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,297 | -42,211 | -30,921 | -20,745 | -9,759 |
| Depreciation Amortization | 205 | 754 | 564 | 371 | 184 |
| Accounts payable and accrued liabilities | -229 | 205 | 74 | 192 | 1,191 |
| Other Working Capital | -3,483 | 1,944 | -1,091 | -140 | -340 |
| Other Operating Activity | 2,090 | 5,210 | 3,840 | 2,118 | -633 |
| Operating Cash Flow | $-12,714 | $-34,098 | $-27,534 | $-18,204 | $-9,357 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -373 | -480 | -198 | -109 | -72 |
| Investing Cash Flow | $-373 | $-480 | $-198 | $-109 | $-72 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,728 | 10,000 | 10,000 | N/A | N/A |
| Debt Repayment | -1,667 | -1,111 | N/A | N/A | N/A |
| Common Stock Issued | 28 | 94,807 | 96,444 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -2,111 | -784 | -19 |
| Financing Cash Flow | $1,089 | $103,696 | $104,333 | $-784 | $-19 |
| Beginning Cash Position | 114,699 | 45,581 | 45,581 | 45,581 | 45,581 |
| End Cash Position | 102,701 | 114,699 | 122,182 | 26,484 | 36,133 |
| Net Cash Flow | $-11,998 | $69,118 | $76,601 | $-19,097 | $-9,448 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,714 | -34,098 | -27,534 | -18,204 | -9,357 |
| Capital Expenditure | -373 | -480 | -198 | -109 | -72 |
| Free Cash Flow | -13,087 | -34,578 | -27,732 | -18,313 | -9,429 |